Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln

Prostatype Genomics AB OMXSTO:PROGEN:

• SAID ON MONDAY RESOLVES ON RIGHTS ISSUE OF UNITS TO RAISE ABOUT SEK 47.4 MILLION BEFORE TRANSACTION COSTS

• SUBSCRIPTION PRICE SET AT SEK 0.80 PER UNIT, EQUIVALENT TO SEK 0.10 PER SHARE

• RIGHTS ISSUE IS SECURED TO ABOUT 70 PERCENT VIA SUBSCRIPTION AND UNDERWRITING COMMITMENTS OF ABOUT SEK 33.15 MILLION

• SAYS FULL EXERCISE OF TO6 AND TO7 WARRANTS COULD PROVIDE ADDITIONAL PROCEEDS OF ABOUT SEK 59.2 MILLION

• SUBSCRIPTION PERIOD TO RUN FROM JULY 9 UP TO AND INCLUDING JULY 23, 2026

• PLANS TO USE NET PROCEEDS TO FINANCE MEDICARE REIMBURSEMENT APPROVAL PROCESS AND COMMERCIALIZATION IN US AND EUROPE

Source text for Workspace:

Further company coverage: